Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 1
1980 1
1981 2
1982 4
1983 6
1984 5
1985 13
1986 10
1987 10
1988 20
1989 16
1990 31
1991 24
1992 27
1993 34
1994 48
1995 59
1996 58
1997 69
1998 91
1999 99
2000 117
2001 122
2002 128
2003 151
2004 150
2005 192
2006 177
2007 211
2008 219
2009 242
2010 277
2011 264
2012 289
2013 297
2014 380
2015 407
2016 391
2017 404
2018 452
2019 520
2020 573
2021 638
2022 667
2023 755
2024 916
2025 147

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,679 results

Results by year

Citations

2 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021.
Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I. Porsteinsson AP, et al. J Prev Alzheimers Dis. 2021;8(3):371-386. doi: 10.14283/jpad.2021.23. J Prev Alzheimers Dis. 2021. PMID: 34101796 Review.
Recently, clinicians have been encouraged to diagnose Alzheimer's earlier, before patients have progressed to Alzheimer's disease dementia. The early and accurate detection of Alzheimer's disease-associated symptoms and underlying dise
Recently, clinicians have been encouraged to diagnose Alzheimer's earlier, before patients have progressed to Alzheimer
Neuropsychiatric symptoms in Alzheimer's disease.
Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, Cedarbaum J, Brashear R, Miller DS. Lyketsos CG, et al. Alzheimers Dement. 2011 Sep;7(5):532-9. doi: 10.1016/j.jalz.2011.05.2410. Alzheimers Dement. 2011. PMID: 21889116 Free PMC article.
Neuropsychiatric symptoms (NPS) are core features of Alzheimer's disease and related dementias. Once thought to emerge primarily in people with late-stage disease, these symptoms are currently known to manifest commonly in very early disease and …
Neuropsychiatric symptoms (NPS) are core features of Alzheimer's disease and related dementias. Once thought to emerge …
The economic and societal burden of Alzheimer disease: managed care considerations.
Skaria AP. Skaria AP. Am J Manag Care. 2022 Sep;28(10 Suppl):S188-S196. doi: 10.37765/ajmc.2022.89236. Am J Manag Care. 2022. PMID: 36197132 Free article.
Alzheimer disease (AD) is the most common cause of dementia and the sixth leading cause of death in the United States. ...Indirect costs such as loss in productivity, diminished quality of life, and an increasing dependence on informal unpaid care provided by fam
Alzheimer disease (AD) is the most common cause of dementia and the sixth leading cause of death in the United States. ...Indi
Alzheimer's disease.
Oboudiyat C, Glazer H, Seifan A, Greer C, Isaacson RS. Oboudiyat C, et al. Semin Neurol. 2013 Sep;33(4):313-29. doi: 10.1055/s-0033-1359319. Epub 2013 Nov 14. Semin Neurol. 2013. PMID: 24234352 Review.
Alzheimer's disease (AD) is the most common neurodegenerative cause of dementia and is responsible for significant individual morbidity and mortality, and economic impact on the health care system. ...We describe the latest criteria for the diagnosis of AD, i
Alzheimer's disease (AD) is the most common neurodegenerative cause of dementia and is responsible for significant individual
Alzheimer Disease.
McDade EM. McDade EM. Continuum (Minneap Minn). 2022 Jun 1;28(3):648-675. doi: 10.1212/CON.0000000000001131. Continuum (Minneap Minn). 2022. PMID: 35678397 Review.
PURPOSE OF REVIEW: Alzheimer disease (AD) is the most common cause of dementia in adults (mid to late life), highlighting the importance of understanding the risk factors, clinical manifestations, and recent developments in diagnostic testing and therapeutics
PURPOSE OF REVIEW: Alzheimer disease (AD) is the most common cause of dementia in adults (mid to late life), highlighting the …
Young-onset dementia diagnosis, management and care: a narrative review.
Loi SM, Cations M, Velakoulis D. Loi SM, et al. Med J Aust. 2023 Mar 6;218(4):182-189. doi: 10.5694/mja2.51849. Epub 2023 Feb 19. Med J Aust. 2023. PMID: 36807325 Free PMC article. Review.
These include primary dementias such as Alzheimer disease, frontotemporal and vascular dementias; genetic/familial dementias; metabolic disorders; and secondary dementias such as those that result from alcohol use disorder, traumatic brain injury, and …
These include primary dementias such as Alzheimer disease, frontotemporal and vascular dementias; genetic/familial dementias; …
Neural oscillations and brain stimulation in Alzheimer's disease.
Jafari Z, Kolb BE, Mohajerani MH. Jafari Z, et al. Prog Neurobiol. 2020 Nov;194:101878. doi: 10.1016/j.pneurobio.2020.101878. Epub 2020 Jun 29. Prog Neurobiol. 2020. PMID: 32615147 Review.
Whereas the primary symptom of amnestic mild cognitive impairment (aMCI) is memory problems greater than normal for age and education, patients with Alzheimer's disease (AD) show impairments in other cognitive domains in addition to memory dysfunction. ...Recent rod …
Whereas the primary symptom of amnestic mild cognitive impairment (aMCI) is memory problems greater than normal for age and education, patie …
Mild Cognitive Impairment: Diagnosis and Subtypes.
Bradfield NI. Bradfield NI. Clin EEG Neurosci. 2023 Jan;54(1):4-11. doi: 10.1177/15500594211042708. Epub 2021 Sep 22. Clin EEG Neurosci. 2023. PMID: 34549629
Various consensus groups have proposed criteria for MCI in Alzheimer's disease (AD), Parkinson's disease, dementia with Lewy bodies, and vascular cognitive impairment. ...The main utilities of MCI as a nosology are to understand the natural history of neurode …
Various consensus groups have proposed criteria for MCI in Alzheimer's disease (AD), Parkinson's disease, dementia with …
Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management.
Singh B, Day CM, Abdella S, Garg S. Singh B, et al. J Control Release. 2024 Mar;367:402-424. doi: 10.1016/j.jconrel.2024.01.047. Epub 2024 Feb 1. J Control Release. 2024. PMID: 38286338 Free article. Review.
Alzheimer's disease (AD), is a neurodegenerative disorder that escalates with time, exerting a significant impact on physical and mental health and leading to death. ...By providing a comprehensive analysis, this review furnishes valuable insights into differ
Alzheimer's disease (AD), is a neurodegenerative disorder that escalates with time, exerting a significant impact on ph
Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients.
Bhattacharya S. Bhattacharya S. Curr Pharm Biotechnol. 2023;24(9):1108-1121. doi: 10.2174/1385272827666221027103050. Curr Pharm Biotechnol. 2023. PMID: 36305141 Review.
Alzheimer's disease is the most common form of dementia. A slew of small molecule inhibitors developed over several decades has targeted dementia and related diseases. ...Drug-loaded nanosized formulations, such as polymeric nanoparticles, solid lipid nano tr
Alzheimer's disease is the most common form of dementia. A slew of small molecule inhibitors developed over several decades ha
8,679 results